3 top FTSE 100 shares for 2017 and beyond

These firms have decent prospects for the long term and the short term.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I’ve been looking at some of the most popular big-cap shares on the London market and asking the question, “How will they fare in 2017 and beyond?” I think these three FTSE 100 companies have some of the most attractive prospects for investors in terms of total returns.

A select few

During my search, I eliminated as much cyclicality as possible, which meant out with the financials, the insurance companies, the commodity firms and retail shares. Out went the troubled supermarket sector, too, and anything else relying on a trading recovery to advance. 

The result is three firms with robust immediate prospects for growth in earnings generated by well-defended market positions. These shares have the potential to reward investors with both capital gains and a rising dividend yield in the years to come.

British American Tobacco (LSE: BATS), Diageo (LSE: DGE) and Reckitt Benckiser Group (LSE: RB) all deal in consumer products that don’t last very long. Because the products are deemed ‘essential’ for many customers, they return repeatedly to re-buy and that tends to lead to stable, predictable inflows of cash for these firms.

Compounding plus benefits

Solid cash flow enables steady dividends, which makes these companies ideal for an investing strategy that focuses on compounding, where dividends are reinvested back into the firms’ shares to create an ever-increasing pot of invested funds.

Compounding is good in itself, but imagine how that compounding pot of funds might be turbocharged if the underlying businesses were growing as well. Rising income and increasing revenue could enable the dividend payments to grow year on year – and the firms’ share prices are likely to rise, too.

There’s good news on that front. City analysts following these companies predict immediate growth in earnings ahead. For 2017, they expect British American Tobacco’s earnings to grow 14%, Diageo’s 16% and Reckitt Benckiser’s 15%.

Between them, these companies deal in products and brands in the sectors of tobacco,  alcoholic drinks, health and hygiene. These are all things that people tend to keep buying no matter how austere the economic times become and it is that quality that makes these shares defensive. 

The defensive/cyclical scale

Contrast defensive businesses with the other end of the scale where cyclical companies reside. The cyclicals tend to deal in goods and services that last longer and which customers often cut from their budgets when times are hard. Cyclicals end up with fluctuating revenues, profits, cash flow and share prices as the macroeconomic environment changes.

Defensive firms like BATS, Diageo and Reckitt Benckiser are more likely to remain evergreen. That makes them ideal investments for the compounding investor. So if other investors lose interest in these companies and the share prices ease off, I’ll be looking to buy more of what I know to be a good thing.

If you are a long-term investor with a focus on compounding, I think it is worth keeping an eye on BATS, Diageo and Reckitt Benckiser with a view to buying the shares — particularly on any sign of share price weakness.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has recommended Diageo and Reckitt Benckiser. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »